Camilo CAMILO Obregón-Berg

Mr. Camilo CAMILO Obregón-Berg

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2025 in International Journal of Drug Policy
Verified
Journal Article
Closed access
MGMauricio Sepúlveda Galeas
Mauricio Sepúlveda Galeas
EEErnesto Escobar
Ernesto Escobar
SSSebastían Ubiergo Scheel
Sebastían Ubiergo Scheel
COCamilo CAMILO Obregón-Berg
Camilo CAMILO Obregón-Berg

2 August 2026 in Journal of Chromatography A
Verified
Journal Article
Closed access
COCamilo CAMILO Obregón-Berg
Camilo CAMILO Obregón-Berg
OGOscar Galarce-Bustos
Oscar Galarce-Bustos
BFBastián Fernández
Bastián Fernández
AGAntonia Gutiérrez
Antonia Gutiérrez
JPJessy Pavon
Jessy Pavon

14 February 2026 in Harm Reduction Journal
Verified
Journal Article
Open access
PDF file
COCamilo CAMILO Obregón-Berg
Camilo CAMILO Obregón-Berg
BFBruno Fuentealba-Donoso
Bruno Fuentealba-Donoso
IVIsidora Vidal
Isidora Vidal
JNJaviera Navarrete
Javiera Navarrete
The health risks for people who use drugs (PWUD) in Chile are exacerbated by evolving drug markets, unpredictable supplies, and the limited availability of

12 May 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
COCamilo CAMILO Obregón-Berg
Camilo CAMILO Obregón-Berg
OGOscar Galarce
Oscar Galarce
BFBastián Fernández
Bastián Fernández
AGAntonia Gutiérrez
Antonia Gutiérrez
JPJessy Pavon
Jessy Pavon
A novel thin-layer chromatography (TLC)-based bioassay coupled with digital image analysis (DIA) was developed for rapid and non-targeted screening of angiotensin-converting enzyme (ACE) inhibitors in complex natural matrices. Conventional ACE inhibitory assays lack spatial resolution and rely on indirect measurements, limiting their applicability for effect-directed analysis (EDA). In this study, an on-surface enzymatic assay was implemented using hippuryl-histidyl-leucine (HHL) as substrate, followed by in situ derivatization of the generated hippuric acid with p-dimethylaminobenzaldehyde (DMAB) in an acetone:acetic anhydride system, producing an orange chromophore directly on the TLC plate. To overcome the inherent subjectivity of visual evaluation, a MATLAB-based DIA workflow was introduced to quantify the colorimetric response as pseudo-absorbance, enabling objective optimization of assay parameters. The blue channel provided the highest analytical sensitivity (R2 = 0.9984), and no significant matrix effects were observed (p = 0.09), confirming the robustness of the approach. Optimal conditions were established at 180 mU mL-1 ACE, 3 mM HHL, 30 min incubation, and 10% (w/v) DMAB. The method was applied to Peumus boldus alkaloidal extracts, enabling clear detection and localization of inhibitory zones poorly resolved by visual inspection. Subsequent isolation by micro-preparative TLC followed by UHPLC–DAD–MS/MS analysis enabled tentative identification of three aporphine alkaloids: norboldine (m/z 314.20 [M+H]+), boldine (m/z 328.10 [M+H]+), and laurotetanine (m/z 328.10 ([M+H]+). This integrated TLC–ACE–DIA platform, complemented by GNPS-assisted MS/MS annotation, provides a rapid, cost-effective, high-throughput strategy for discovery and prioritization of ACE inhibitors in natural products, significantly enhancing analytical capabilities of effect-directed analysis workflows.